The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study

BACKGROUND: Dopamine D2-like receptors are attenuated in aldosterone producing adenoma, lead to overproduction of aldosterone in affected patients, and thus reported to serve as a potential treatment target for primary aldosteronism. The D2 dopamine receptor agonist bromocriptine has been used clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Vin-Cent, Wu, Che-Hsiung, Yang, Ya-Wen, Huang, Kuo-How, Chang, Chia-Hui, Yang, Shao-Yu, Lin, Yen-Hung, Wu, Kwan-Dun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652803/
https://www.ncbi.nlm.nih.gov/pubmed/29100412
http://dx.doi.org/10.18632/oncotarget.20670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652803/
https://www.ncbi.nlm.nih.gov/pubmed/29100412
http://dx.doi.org/10.18632/oncotarget.20670

Ejemplares similares